Lilly sees launching weight loss drugs in China, India starting late 2025 – Seeking Alpha
Lilly sees launching weight loss drugs in China, India starting late 2025 Seeking Alpha
Novo’s Wegovy successor disappoints in second large trial – BioPharma Dive
Novo’s Wegovy successor disappoints in second large trial BioPharma Dive
Novo Nordisk shares fall on weight-loss drug trial – MSN
Novo Nordisk shares fall on weight-loss drug trial MSN
Novo Nordisk shares fall on weight-loss drug trial – Fox Business
Novo Nordisk shares fall on weight-loss drug trial Fox Business
IA-2A positivity identified as a key predictor in type 1 diabetes progression
A recent study published in Diabetologia has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a…
Novo Nordisk shares fall on weight loss drug trial results – Proactive Investors USA
Novo Nordisk shares fall on weight loss drug trial results Proactive Investors USA
Novo Nordisk Stock Drops on New Obesity Drug Findings. Eli Lilly Stands to Gain. – Barron’s
Novo Nordisk Stock Drops on New Obesity Drug Findings. Eli Lilly Stands to Gain. Barron’s